Focused on growth
With strong regional roots and an established track record, Mercia is a ‘one stop’ responsible financial partner contributing towards the growth of the UK economy.Dr Mark Payton, CEO, Mercia
Non-executive Chair's statement
The significant profitable and cash generative growth that we have achieved during this period has been funded entirely from our own financial resources, without dilutive recourse to shareholders or the need to borrow from third-parties. We see no need for this to change in the foreseeable future.
CEO's review
Whilst the sector that we operate in has generally seen liquidity pressures and material reductions in portfolio values, we see an opportunity during this current financial year to increase our investment activity by taking advantage of our strong, unrestricted liquidity of c.£378million across the Group.
Mercia by numbers
Group AuM (FY22: c.£959m)
NAV/share (FY22: 45.6p)
Capital deployed (FY22: c.£124m)
Cash realised (FY22: c.£155m)
Group revenue (FY22: £23.2m)
Proposed final dividend (FY22: 0.50p/share)
Adjusted operating profit (FY22: £8.4m)
Cash* (FY22: £61.3m)
* Including short-term liquidity investments
Invincibles Studio
Global fantasy football games developer
We sit down with Co-founder and CEO, Chris Gore, and CFO, Max Lowe, about the growth of one of the world’s favourite fantasy football sim.
nDreams
The growth of virtual reality
Mercia TV sits down with nDreams CEO and Founder, Patrick O’Luanaigh, where he tells us all about the inception of the company, what it was like producing the incredible Ghostbusters VR, its expansion, the current VR market and what the future has in store for the Farnborough-based company.
Medherant
Developing innovative transdermal drug delivery patches for women’s health
Medherant announced in April that it has raised £2.9m of new funding from investors in a financing round led by Mercia Asset Management.
Watch as CEO, John Burt and Dr Gabit Nurumbetov talk through its bespoke transdermal drug delivery patches and how the funding is being used to progress development of a testosterone transdermal patch for post-menopausal women into clinical development.
Pimberly
The world’s most powerful PIM platform
Founder and CEO, Martin Balaam and VP Operations, Mike Walker, talk to Mercia TV about how Pimberly‘s platform has become the ‘go-to’ Product Information Management (PIM) platform on the planet, with clients including JD Sports, Harvey Nichols and Monsoon.
Mercia's ESG - who makes it happen
Value-based support from across Mercia
We have set out key considerations and documented our EGS reporting baselines. These are not arbitrary targets simply to be ticked off a list, but fundamental principles that we must adopt to drive behaviours.
The ESG arena continues to be subject to rapid change which is why we have adopted regular responsible investment committee meetings. The committee is made up of employees from across the business representing a range of business functions, seniorities and backgrounds and it is this team which help to drive our strategy and initiatives.
We recognise that we operate in an industry where much more can be done, we feel it is our responsibility to push the boundaries on what can be achieved. This is why Mercia has gone further and, in 2023, we added a core value of ‘responsible’ – a belief and principle that guides and influences all of our behaviours, decisions and actions.
Preliminary results presentation FY23
Mercia’s hybrid model, which combines profitable FuM with maturing balance sheet investment, is proven to work in both good times and during challenging conditions.Dr Mark Payton, Chief Executive Officer
Annual Report 2023
These results demonstrate Mercia’s robust business fundamentals, during a year of significant market and economic instability.
– Martin Glanfield, Chief Financial Officer